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Abstract. 
 
Membrane fusion and budding are key steps 
in the life cycle of all enveloped viruses. Semliki Forest 
virus (SFV) is an enveloped alphavirus that requires 
cellular membrane cholesterol for both membrane fu-
sion and efficient exit of progeny virus from infected 
cells. We selected an SFV mutant, srf-3, that was strik-
ingly independent of cholesterol for growth. This phe-
notype was conferred by a single amino acid change in 
the E1 spike protein subunit, proline 226 to serine, that 
increased the cholesterol independence of both srf-3 fu-
sion and exit. The srf-3 mutant emphasizes the relation-
ship between the role of cholesterol in membrane fu-
sion and virus exit, and most significantly, identifies a 
novel spike protein region involved in the virus choles-
terol requirement.
 
M
 
embrane 
 
fusion is a critical and ubiquitous cellu-
lar process involved in the formation and traf-
ficking of endocytic and exocytic vesicles, and in
fusions between cells. It is becoming apparent that mem-
brane lipid composition is strategically involved in the
control of membrane budding, protein transport, and
membrane fusion (Pfanner et al., 1990; De Camilli et al.,
1996; Kearns et al., 1997), but the role of specific lipids and
their interactions with cellular proteins are not yet clear. A
striking example of a defined lipid requirement in mem-
brane fusion is the Semliki Forest virus (SFV)
 
1
 
 fusion pro-
tein, which mediates the cholesterol and sphingolipid-
dependent fusion of the virus membrane with the cellular
membrane during virus infection.
SFV is a member of the alphaviruses, enveloped positive–
stranded RNA viruses with highly ordered icosahedral
structures in which the spike and capsid proteins interact
in a one-to-one association (reviewed in Strauss and
Strauss, 1994; Kielian, 1995). The spike proteins also form
extensive lateral interactions, and constitute a protein layer
that almost completely covers the virus lipid bilayer (Cheng
et al., 1995; Fuller et al., 1995). This simple virus structure
protects the virus RNA genome, mediates virus fusion
with the cell membrane to release the nucleocapsid and
initiate infection, and is efficiently assembled during the
budding of progeny virions from the host cell plasma
membrane. SFV is a highly developed system to study vi-
rus membrane fusion and budding, two key steps in infec-
tion by all enveloped viruses.
SFV infects cells by cell surface receptor binding, uptake
via receptor-mediated endocytosis, and low pH-triggered
fusion of the virus membrane with that of the endosome.
Virus membrane fusion is carried out by the 80 spike
proteins on the surface of the virus. The spike proteins are
trimers containing a complex of the E1, E2, and E3 gly-
copolypeptides, (E1/E2/E3)
 
3
 
. E1 and E2 are type 1 trans-
membrane proteins of 
 
z
 
50 kD, and E3 is a peripheral
polypeptide of 
 
z
 
10 kD. E1 is the fusion-active spike pro-
tein subunit, and a soluble ectodomain form of E1 has
been shown to bind membranes in a low pH-dependent re-
action (Klimjack et al., 1994). Upon exposure to low pH,
the SFV spike protein undergoes a defined series of con-
formational changes (Garoff et al., 1994; Kielian, 1995).
The normally tight dimeric interaction between the E1
and E2 transmembrane subunits is weakened, E1 exposes
new antigenic epitopes, forms a trypsin-resistant homotri-
mer, and associates with the target membrane. E1 contains
the putative virus fusion peptide, a highly conserved hy-
drophobic domain between amino acids 79–97 (Garoff et al.,
1980). The importance of these conformational changes
and the E1 fusion peptide is supported by the fact that a
mutation within the fusion peptide, glycine 91 to aspartate,
blocks both the formation of the E1 homotrimer and
membrane fusion (Levy-Mintz and Kielian, 1991; Kielian
et al., 1996).
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In addition to the requirement for low pH, SFV fusion
has a striking requirement for specific lipids in the target
membrane. Fusion requires cholesterol, with optimal con-
centrations of one cholesterol molecule per two phospho-
lipids (White and Helenius, 1980). Fusion is also depen-
dent on the presence of small amounts (
 
z
 
2 mol%) of
sphingolipid in the target membrane (Nieva et al., 1994;
Moesby et al., 1995). The SFV cholesterol requirement
does not involve the general membrane fluidizing proper-
ties of cholesterol, but seems to be specific for the sterol
3
 
b
 
-hydroxyl group (Kielian and Helenius, 1984). The mo-
lecular mechanism by which cholesterol affects fusion is
unclear at present, but cholesterol is required for the hy-
drophobic interaction of the virus with the target mem-
brane before fusion (Kielian and Helenius, 1984; Bron et al.,
1993; Nieva et al., 1994). In addition, cholesterol is specifi-
cally required for both the membrane binding of the E1
ectodomain, and its acid-dependent conformational changes
such as epitope exposure, homotrimerization, and acquisi-
tion of trypsin resistance (Kielian and Helenius, 1985; Kie-
lian et al., 1990; Klimjack et al., 1994).
To evaluate the role of cholesterol in vivo, we used the
observation that insects are cholesterol auxotrophs (Nes
and McKean, 1977), and that insect cells, unlike mamma-
lian or avian cells, can be cholesterol-depleted without del-
eterious effects (Silberkang et al., 1983). Previously, we
depleted the C6/36 mosquito cell line to 
 
,
 
2% of the con-
trol level of cholesterol, and showed that the depleted cells
are unaltered in their endocytic uptake and acidification
properties, and are permissive for infection by vesicular
stomatitis virus, an unrelated, cholesterol-independent vi-
rus (Phalen and Kielian, 1991). However, as predicted from
the in vitro studies, depleted cells are blocked in SFV fu-
sion and infection, and the block is specifically reversed by
cholesterol addition. The depleted C6/36 cells are reduced
about 5,000-fold in SFV infection efficiency compared to
controls (Marquardt and Kielian, 1996). Using transfec-
tion of viral RNA or very high multiplicity infection, we
then evaluated the involvement of cholesterol in the SFV
exit pathway (Marquardt et al., 1993). Unexpectedly, our
studies demonstrated that cholesterol is also involved in
the efficient production of progeny virus. Thus, choles-
terol seems to play two critical roles in the SFV life cycle,
one involving virus fusion and one involving a late step in
the formation or release of virus particles.
Given that SFV growth is strongly inhibited in choles-
terol-depleted cells, we have now exploited this cell cul-
ture system to select for virus mutations that would permit
growth in the absence of cholesterol. Such mutants were
termed srf mutants, for sterol requirement in function. We
previously showed that the srf phenotype allows more effi-
cient virus exit from sterol-depleted cells (Marquardt et
al., 1993). Characterization and molecular analysis of a srf
mutant here reveals that the mutant’s infection efficiency,
membrane fusion, growth rate, and exit were all markedly
less cholesterol-dependent than those of the parental vi-
rus. We demonstrate that the mutant has a single amino
acid substitution on the E1 spike protein subunit, proline
226 to serine, which conferred these cholesterol-indepen-
dent properties. This mutant thus identifies a novel region
of E1, separate from the fusion peptide, that is involved in
the cholesterol requirement for SFV fusion and exit.
 
Materials and Methods
 
Cells
 
BHK-21 cells were cultured at 37
 
8
 
C in DME containing 100 U/ml penicil-
lin and 100 
 
m
 
g/ml streptomycin, supplemented with 5% FCS and 10%
tryptose phosphate broth. C6/36 cells, a clonal cell line from 
 
Aedes albo-
pictus
 
, were cultured at 28
 
8
 
C in DME supplemented with 10% heat-inacti-
vated FCS (Phalen and Kielian, 1991). Cholesterol-depleted C6/36 cells
were prepared by four or more passages in DME containing 10% heat-
inactivated FCS previously treated with colloidal silica to remove lipopro-
teins (Phalen and Kielian, 1991; Marquardt et al., 1993; Marquardt and
Kielian, 1996). Depleted cells were repleted with either cholesterol or
chlorocholestene (5-cholestene-3
 
b
 
-chloro) (Steraloids Inc., Wilton, NH)
by adding either a sterol-BSA emulsion or a stock solution of sterol in eth-
anol to the depleted cell medium, and incubating the cells overnight
(Phalen and Kielian, 1991; Marquardt et al., 1993; Marquardt and Kielian,
1996). Identical results were obtained using control or cholesterol-repleted
C6/36 cells.
 
Isolation of SFV Mutants with Altered
Sterol Requirements
 
A plaque-purified wild-type (wt) stock of SFV (Kielian et al., 1984) was
mutagenized to 
 
z
 
20% viability by treatment with 1-methyl-3-nitro-1-nitro-
soguanidine (Kielian et al., 1984). The mutagenized stock was grown for 6 h
at 37
 
8
 
C on BHK cells at a multiplicity of 0.5 pfu/cell to allow expression of
mutant phenotypes. A starting titer of 10
 
7
 
 pfu of this virus stock was then
selected by growth on one plate of chlorocholestene-repleted cells at 0.5
pfu/cell for 48 h in MEM containing 0.2% BSA and 10 mM Hepes, pH 7.0.
The selection was repeated by two more passages on chlorocholestene-
repleted cells at a starting multiplicity of 
 
<
 
0.1 pfu/cell. At this point, the
selected virus stock was found to have 
 
z
 
100-fold greater infectivity on
chlorocholestene-repleted cells than the parental wt virus. Potential mu-
tants were then isolated by limiting dilution on chlorocholestene-repleted
cells grown in 96-well tissue culture trays. Cells were infected with 10-fold
serial dilutions of virus, and cultured for 2 d at 28
 
8
 
C in serum-free medium
(OptiMEM; GIBCO BRL, Gaithersburg, MD) supplemented with 0.2%
BSA and 100 U/ml penicillin and 100 
 
m
 
g/ml streptomycin. Medium from
the wells was harvested and stored on ice. Wells containing virus able to
replicate efficiently in the absence of cholesterol were identified by stain-
ing cells with a polyclonal antibody to the SFV spike protein (Kielian et
al., 1990), peroxidase-conjugated second antibody, and 3-amino-9-ethyl-
carbozole substrate, and visualizing by light microscopy. Wells with
strongly positive-infected cells were identified as containing potential vi-
rus mutants, and the medium from such positive wells at viral dilutions
yielding 
 
<
 
60% positive wells was then used for two additional rounds of
limiting dilution. Five potential mutants were isolated, three of which
grew to sufficient titers to permit further expansion by three to four suc-
cessive low multiplicity passages on chlorocholestene-repleted cells. These
isolates were termed srf-1, -2 and -3, for sterol requirement in function.
Other selections based on nonmutagenized virus or low pH-induced vi-
rus–plasma membrane fusion did not result in isolation of mutants.
 
Preparation of Radiolabeled Virus
 
Wt SFV and srf mutants were radiolabeled and purified by infecting con-
trol, depleted, or chlorocholestene-repleted C6/36 cells for 6 h at multi-
plicities of 150 pfu/cell, labeling for 18 h in methionine/cysteine free DME
containing 150 mCi/ml [
 
35
 
S]methionine/cysteine, followed by pelleting and
purification on discontinuous 10–20%/25–50% sucrose gradients contain-
ing a 600 
 
m
 
l 50% sucrose cushion (Kielian et al., 1984).
 
Assays of Virus–Cell Interactions
 
Binding of radiolabeled wt SFV or srf mutants to C6/36 or BHK cells
was measured as previously described (Phalen and Kielian, 1991). En-
docytosis of radiolabeled virus was followed by measuring lysosomal deg-
radation and the release of acid-soluble radioactivity (Phalen and Kielian,
1991). Growth curves of wt and mutants on control or depleted C6/36 cells
were performed at multiplicities of 1 pfu/cell, and titered on BHK cells
(Marquardt and Kielian, 1996). Primary infection of C6/36 cells was quan-
titated by an infectious center assay using immunofluorescence with a
polyclonal antibody to the SFV spike protein to detect infected cells (Mar- 
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quardt and Kielian, 1996). Fusion of prebound virus with control or sterol-
modified cells was induced by treatment for 1 min, pH 5.5, at 28
 
8
 
C. Cells
were then incubated overnight in medium containing 20 mM NH
 
4
 
Cl to
prevent secondary infection, and infected cells quantitated by immunoflu-
orescence (Marquardt and Kielian, 1996). Exit of newly synthesized virus
from wt and mutant-infected C6/36 cells was followed by pulse–chase
analysis as previously described, using increased multiplicity and radiola-
bel to assay wt virus in cholesterol-depleted cells (Marquardt et al., 1993;
Marquardt and Kielian, 1996). Fluorograms were quantitated using a
PhosphorImager and ImageQuant software from Molecular Dynamics,
Inc. (Sunnyvale, CA).
 
Virus Sequence Analysis
 
Viral RNA was prepared by the method of Ou et al. (1981), using purified
wild-type virus propagated on BHK cells, and pelleted srf-3 virus propa-
gated on chlorocholestene-repleted C6/36 cells. 1 
 
m
 
g of viral RNA was re-
verse transcribed in a 20-
 
m
 
l reaction using oligo dT as a primer and 40 U
of AMV reverse transcriptase, as previously described (Kielian et al.,
1996). 2–4 
 
m
 
l of the resultant cDNA were then amplified using 500 ng
each of primers within E1 and E2 in a 50-
 
m
 
l reaction containing Vent poly-
merase (New England Biolabs, Inc., Beverly, MA) (Kielian et al., 1996).
The amplified DNA was purified using a QIAquick kit (Qiagen Inc.,
Chatsworth, CA), and both strands of the DNA encoding E1 and 6K were
sequenced by the automated sequencing facility at the Albert Einstein
College of Medicine (Kielian et al., 1996). Several independent RT-PCR
products were sequenced to control for possible errors during transcrip-
tion and amplification. The E1 sequence from srf-1 was obtained using the
virus resulting from infection of one 75-cm
 
2
 
 flask of cholesterol-depleted
C6/36 cells. All of the viral RNA was used for reverse transcription, and
2–4 
 
m
 
l of resulting cDNA were used for amplification and sequencing as
above. The E1 sequence from srf-2 was obtained using total cellular RNA
from a 100-mm plate of cholesterol-depleted C6/36 cells infected at 1 pfu/
cell at 28
 
8
 
C for 24 h. Total cellular RNA was extracted using the RNAzol
method and 8 
 
m
 
g RNA was reverse transcribed, as described previously
(Kielian et al., 1996), and used for amplification and sequencing as above.
 
Infectious SFV Clones
 
The mutation in srf-3 was mapped by transferring a unique 2.1-kb NdeI
fragment containing srf-3 nucleotides 8929–11033 into the wt infectious
SFV clone. cDNA from srf-3 was prepared as described above, and PCR-
amplified using oligos 3
 
9
 
 to the E1 sequence and within E2 to generate an
 
z
 
2.5-kb product that was then digested with NdeI. The wild-type infec-
tious clone pSP6-SFV4 was digested to completion with NdeI, the large
fragment self-ligated and propagated, treated with NdeI and phosphatase,
and ligated with the srf-3 NdeI fragment to regenerate the complete infec-
tious clone. Individual clones were transcribed using SP6 polymerase
(Duffus et al., 1995), and the RNAs tested for primary and secondary in-
fection on control and cholesterol-depleted C6/36 cells. 50–100 ng of RNA
was mixed with 40 
 
m
 
g lipofectin in 250 
 
m
 
l of OptiMEM (GIBCO BRL).
Depleted or control C6/36 cells grown on 12 mm coverslips in 24-well
trays were incubated with this mixture for 1 h, and then cultured for 
 
z
 
18 h
in OptiMEM/0.2%BSA with or without 20 mM NH
 
4
 
Cl to prevent second-
ary infection (Marquardt et al., 1993). The cells were then fixed and virus
infection assayed by indirect immunofluorescence using an antibody to the
SFV spike protein (Marquardt and Kielian, 1996). A clone that produced
efficient secondary infection of both control and depleted C6/36 cells was
chosen, and used to make a virus stock by lipofection of the transcribed
RNA into depleted C6/36 cells. The clone and the recombinant virus stock
were referred to as srf-3/ic. The entire NdeI fragment of the srf-3/ic was
sequenced on both strands by automated sequencing. Sequences were
compared to the original published sequence of SFV spike proteins (Ga-
roff et al., 1980), the sequence of pSP6-SFV-4 in the database, and the se-
quence of our plasmid isolate of pSP6-SFV-4, termed wt/ic. In addition,
we performed RT-PCR and sequence analysis of RNA from the parent vi-
rus to srf-3, which is our plaque-purified strain of SFV (Kielian et al.,
1984). srf-3 and srf-3/ic contained a unique but silent change at valine 3 of
6K (GUG-GUU), and a change from the published sequence of E1 aspar-
agine 323 to aspartic acid (AAC-GAC). Sequence analysis of both wt/ic
and the srf-3 parent strain showed that they also have Asp 323, however,
and thus the Asn 323 sequence in the database is probably due to an early
sequencing error. The only amino acid change in the NdeI fragment be-
tween srf-3/srf-3/ic and the parent virus/published sequences was due to a
single base change, from a CCC to UCC in the srf-3 RNA, producing the
E1 proline 226 to serine substitution. Mutation of C to U has been previ-
ously observed in other alphavirus mutants isolated following nitro-
soguanidine treatment (Lindqvist et al., 1986).
The E1 P226S mutation was introduced de novo into the wild-type in-
fectious clone by PCR mutagenesis using the overlap extension method
(Levy-Mintz and Kielian, 1991). The sequence of the 5
 
9
 
-3
 
9
 
 mutagenic
oligo was GCCCTTCAtCaGGCATGG, and the mutagenized fragment
was subcloned into pSP6-SFV4 using the NdeI sites as described above.
The P226S mutagenesis also introduced an EcoNI site which was used ini-
tially to screen the clones. A clone, termed SFV4-P226S, was selected, and
a virus stock was generated by RNA transcription and lipofection as above.
The entire NdeI fragment from SFV4 P226S was sequenced and con-
firmed that no additional changes were introduced during mutagenesis.
 
Results
 
Isolation of Semliki Forest Virus Mutants with 
Decreased Cholesterol Requirements
 
Given the central role of cholesterol in SFV fusion and
exit, we hypothesized that it might be impossible to select
sterol-independent SFV mutants. We therefore selected
for mutants able to use chlorocholestene, a cholesterol an-
alogue that is normally nonfusogenic and contains chlo-
ride at the 3
 
b
 
 position. A mutagenized stock of SFV was
grown for three successive low multiplicity passages on
cholesterol-depleted cells enriched with chlorocholestene.
The selected virus stock showed a 
 
z
 
100-fold increase in
infectivity on chlorocholestene-enriched cells compared to
that of wt virus. Because SFV does not produce plaques on
C6/36 cells (Brown and Condreay, 1986), potential mu-
tants in this stock were isolated by limiting dilution on C6/
36 cells enriched with chlorocholestene, resulting in three
putative mutant isolates. These were termed srf-1, srf-2
and srf-3 for the purposes of phenotypic characterization,
although the procedure used to isolate them did not guar-
antee that they were independent mutants.
 
Cholesterol Independence of srf Mutants
 
To determine the cholesterol requirements of the srf mu-
tants, we first compared their growth kinetics in control,
chlorocholestene-enriched, and sterol-depleted C6/36 cells,
measuring the production of progeny virus by plaque as-
says on BHK cells. Growth of all four viruses on choles-
terol-containing cells was rapid and efficient, resulting in
titers of 
 
z
 
10
 
9
 
 pfu/ml by 12 h after infection (Fig. 1 
 
A
 
). The
 
srf
 
 mutants did not exhibit a significant growth advantage,
arguing that they were simply not better able to replicate
in mosquito cells. As expected, the wt virus grew much less
efficiently on chlorocholestene-enriched cells compared to
control cells, with titers about four logs lower at 12 h and
three logs lower at 48 h (Fig. 1 
 
B
 
). In contrast, all three
mutants grew more efficiently than wt on chlorocholes-
tene-enriched cells, showing titers four to five logs higher
than wt by 24 h. Although the mutants grew more slowly
on chlorocholestene-enriched cells than control cells, the
final yield of mutant virus was comparable in the two cell
types. In cholesterol-depleted, nonenriched cells, growth
of wt virus was severely impaired, producing titers of only
10
 
5
 
 pfu/ml even after a 48-h infection of depleted cells
(Fig. 1 
 
C
 
). Surprisingly, the mutants were able to replicate
on cholesterol-depleted cells that were not enriched with
chlorocholestene. Although the growth kinetics were slower
than on control cells, final titers of 
 
z
 
10
 
9
 
 pfu/ml were ob- 
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tained. Thus, the three srf mutants were dramatically al-
tered in their cholesterol requirements for growth. Al-
though the mutants were originally selected for growth on
chlorocholestene-enriched cells, in fact they appeared to
be relatively sterol independent. This may reflect a lack of
chlorocholestene incorporation in the enriched cell mem-
brane, as discussed below. The srf-3 mutant was selected
for further study.
The growth properties of SFV are a function of its re-
quirements for cholesterol in fusion (entry) and viral exit
from cells. To determine the initial role of cholesterol in
srf entry and fusion, we compared the ability of wt and srf-3
to infect control and cholesterol-depleted C6/36 cells using
an infectious center assay (Fig. 2 
 
A
 
). In agreement with
our previous results (Marquardt et al., 1993; Marquardt
and Kielian, 1996), there was a four log difference in the
ability of wt SFV to infect control cells versus depleted
cells. In contrast, although srf-3 most efficiently infected
cells with cholesterol, its ability to infect cholesterol-
depleted cells was increased about 100-fold compared to
that of wt virus. This substantial increase in infection of
sterol-depleted cells was not due to a comparable increase
in srf-3’s infectivity on mosquito cells, such as a host range
mutation. This is apparent from the similar growth kinetics
of wt and mutants on control C6/36 cells (Fig. 1 
 
A
 
). In ad-
dition, wt and mutant viruses showed similar ratios of in-
fection on cholesterol-containing BHK cells and mosquito
cells (Table I). It is unclear whether the slight increase in
infectivity of all four viruses on BHK cells reflects techni-
cal differences between plaque assays and infectious cen-
ter assays, or host cell differences.
The increased ability of srf-3 to infect depleted cells
could be due to an increase in receptor binding, endocytic
uptake, or fusion with the endosome membrane. Virus-
receptor binding and endocytosis were measured using pu-
rified 
 
35
 
S-labeled wt and srf-3 in control and depleted cells,
and were comparable in all cases (data not shown). We
then specifically assayed the ability of wt and srf-3 to fuse
with the plasma membrane bilayer of control and depleted
cells. Virus was bound to cells in the cold and treated
briefly at low pH to trigger fusion with the plasma mem-
brane. The cells were then cultured for 12 h in the pres-
ence of ammonium chloride to block secondary infection,
and infected cells quantitated by immunofluorescence.
Under these conditions, infection only results from direct
low pH-triggered fusion of bound virus with the plasma
membrane (Helenius et al., 1982). As expected from previ-
ous liposome fusion assays, wt virus–plasma membrane fu-
sion was strongly cholesterol dependent (Fig. 2 
 
B
 
). In con-
trast, although the srf-3 mutant showed a preference for
cholesterol-containing cells, its ability to fuse with the de-
pleted cell membrane was increased about three logs com-
pared to wt virus. Similar cholesterol-independent fusion
was observed when srf-1, 
 
-
 
2, or 
 
-
 
3 were assayed on either
depleted cells or chlorocholestene-enriched cells (data not
shown). Taken together, these data strongly suggest that
the increased infectivity of srf mutants on sterol-depleted
cells was caused by an increase in their cholesterol-inde-
pendent membrane fusion activity.
We compared the cholesterol dependence of wt SFV
and srf exit, using pulse–chase analysis in control and cho-
Figure 1. Growth of wt and srf mutants in control and sterol-
modified C6/36 cells. Wild-type or mutant viruses were prebound
on ice for 1 h to control or sterol-modified C6/36 cells at a multi-
plicity of 1 pfu/cell. Infection was initiated by warming the cells to
288C for 1.5 h. The cells were then washed to remove input virus,
incubation continued at 288C, and samples were taken at the indi-
cated times for plaque titration on BHK cells. Representative ex-
ample of two experiments. 
Figure 2. Infectivity and fu-
sion of wt and srf-3 in control
and cholesterol-depleted C6/
36 cells. (A) Infection. Con-
trol (1) and sterol-depleted
(2) cells were infected with
serial dilutions of wt and srf-3,
and primary infection was
quantitated by immunofluo-
rescence. Infection was nor-
malized to 105 infectious cen-
ters/ml on control cells. Data
shown are the average of 13
determinations. (B) Fusion.
Serial dilutions of virus were
bound to control (1) or de-
pleted (2) cells in the cold,
and the cells treated for 1
min at pH 5.5 to trigger virus
fusion with the plasma mem-
brane. Infected cells resulting
from virus fusion were quan-
titated by immunofluores-
cence, and normalized to 106
infectious centers/ml on con-
trol cells. Data shown are the
average of six determinations
for wt and seven determina-
tions for srf-3.
 
Table I. srf Mutants Do Not Have an Altered Host Range
 
Virus
Ratio of titer on BHK cells
to titer on control C6/36 cells
 
Wild type 32
srf-1 28
srf-2 37
srf-3 19
 
Virus stocks were titered on BHK cells by standard plaque assay. The titer on control
C6/36 cells was determined by infectious center assay. Representative data from one
of two experiments are shown. 
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lesterol-depleted cells (Marquardt et al., 1993; Marquardt
and Kielian, 1996). wt SFV exit was inhibited in choles-
terol-depleted cells compared to control cells, with total
radiolabeled spike proteins released in virus particles by
90 min chase averaging 24% in control cells and 2% in de-
pleted cells (
 
n
 
 
 
5
 
 7). In contrast, srf-3 exit averaged 32%
from control cells and 16% from depleted cells (
 
n
 
 
 
5
 
 6).
srf-1, -2, and -3 showed similar increases in exit from cho-
lesterol-depleted cells. Electron microscopy showed that
srf virions budding from sterol-depleted cells appeared
morphologically similar to srf or wt virions released from
control cells (data not shown; Marquardt et al., 1993).
Thus, the srf mutants are increased in both their ability to
fuse with and exit from cholesterol-depleted cells. These
data also suggest that the cholesterol requirement for wt
virus fusion may be more stringent than that for virus exit
(see also Marquardt and Kielian, 1996). To test the genetic
stability of the srf mutants, srf-3 was passaged on either
depleted C6/36 cells, chlorocholestene-enriched C6/36
cells, control C6/36 cells, or BHK cells. The srf phenotype
was then assayed by comparing its infectivity on C6/36
cells with and without cholesterol (Table II). srf-3 showed
dramatically increased infectivity on depleted cells irre-
spective of its passage history, and thus the srf-3 mutation
is stable for at least one passage in the absence of selective
pressure. In parallel, we assayed wt virus that had been
passaged on control C6/36 cells, and found that its infectiv-
ity was strongly cholesterol-dependent (Table II), in
agreement with the results using BHK-grown virus (Fig. 2
 
A
 
). Thus, the srf-3 phenotype appears to be due to a virus
mutation, rather than to differences in lipid and carbohy-
drate composition between mammalian and mosquito
grown virus (Kielian, 1995).
 
Role of Cholesterol in SFV Structure
 
The srf mutants grew to comparable final titers in either
control or sterol-depleted cells (Fig. 1), and showed similar
overall morphology in the absence of cholesterol. These re-
sults suggested that once formed, the virus particle was in-
dependent of cholesterol until virus fusion was triggered.
However, during purification of radiolabeled srf-3 we dis-
covered an important role of cholesterol in virus particle
stability. When srf-3 was prepared from depleted cells and
centrifuged on a standard sucrose gradient, the virus was
found to be highly unstable to shear force, and dissociated
during centrifugation to give a visible, more slowly sedi-
menting band in the gradient (Fig. 3 
 
B
 
). Electron micros-
copy revealed that this lower density peak consisted of
capsid-free virus membranes, and that even the peak at
approximate normal density contained highly disorga-
nized virus particles (data not shown). In contrast, srf-3
grown in the presence of cholesterol showed similar sedi-
mentation properties as wt SFV (Fig. 3 
 
A
 
). This effect of
cholesterol is surprising given the efficient growth proper-
ties of the srf mutants on depleted cells, and suggests a
critical role of cholesterol in the virus structure. Such a
role could explain the requirement for cholesterol in the
efficient exit of SFV from the host cell. Enrichment of de-
pleted cells with chlorocholestene did not protect the virus
from disruption by shear force (data not shown), suggest-
ing either that this sterol does not partition significantly into
the plasma membrane, or that it does not structurally sub-
stitute for cholesterol.
 
Mutation Responsible for Cholesterol Independence
 
To define the mutation that confers srf cholesterol inde-
 
Table II. The srf-3 Mutation Is Stable
 
Virus/passage history
Ratio of titer on control C6/36 cells
to titer on sterol-depleted C6/36 cells
 
Experiment 1
Wild type/control C6/36 cells 17,860
srf-3/chlorocholestene C6/36 cells 14
srf-3/depleted C6/36 cells 7
srf-3/control C6/36 cells 12
Experiment 2
Wild type/control C6/36 cells 5,433
srf-3/chlorocholestene C6/36 cells 77
srf-3/BHK cells 55
 
To test the stability of the srf-3 phenotype, virus stocks were grown for 
 
z
 
 24 h (BHK)
or 48 h (C6/36) at multiplicities of 0.01 pfu/cell (BHK) or 0.05 pfu/cell (C6/36). The
resulting virus stocks were then titered by infectious center assay on control and cho-
lesterol-depleted C6/36 cells.
Figure 3. Cholesterol is required for virus membrane stability.
(A) [35S]methionine-labeled wt SFV or srf-3 were prepared by
growth in control C6/36 cells. (B) [35S]methionine-labeled srf-3
was prepared by growth in cholesterol-depleted C6/36 cells. Radio-
labeled viruses were pelleted, centrifuged on sucrose gradients,
the gradients fractionated, and radioactivity determined by scin-
tillation counting. Sedimentation is to the left. Representative ex-
ample of two experiments.  
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pendence, we reasoned that the key alteration was prob-
ably in the virus spike protein. The central role of E1 in
fusion and the cholesterol dependence of its membrane
binding and acid-induced conformational changes sug-
gested that it would be the spike subunit most likely to
carry the mutation (Klimjack et al., 1994; Kielian, 1995).
We prepared RNA from srf-3, and performed RT-PCR
amplification. A unique 2.1-kb NdeI fragment encoding
most of the srf-3 E1, all of 6K, and the COOH terminal
half of the E2 sequence was substituted into the wt infec-
tious SFV clone pSP6-SFV-4 (Liljestrom et al., 1991). This
DNA construct, termed srf-3/ic, was used for in vitro tran-
scription of infectious SFV RNA and generation of a virus
stock. The NdeI fragment converted the infectious clone-
derived virus to cholesterol-independent growth (Fig. 4),
and also conferred the srf-3 infection, fusion, and exit
properties (data not shown). DNA sequence analysis was
performed on this cloned fragment and on several inde-
pendent RT-PCR products derived from srf-3 RNA. The
only amino acid change in the NdeI fragment between srf-3
and the parent virus was due to a single base change, from
CCC to UCC in the srf-3 RNA, producing a substitution of
proline 226 to serine on the viral E1 (P226S). RT-PCR and
sequence analysis of the P226 regions of srf-1 and srf-2 in-
dicated that both contained the P226S mutation, suggesting
that the three mutants are separate isolates of the same
original mutant that arose during the growth of the virus
stock on cholesterol-depleted, chlorocholestene-enriched
cells. The results indicated that a single amino acid change
could be responsible for the decreased cholesterol depen-
dence of both fusion and exit.
To confirm the identity of the critical mutation, we in-
troduced the P226S change de novo into the infectious clone
using in vitro mutagenesis. The virus derived from this clone
(P226S) was then tested for growth on depleted cells, and
showed similar efficient growth in the absence of choles-
terol as srf-3 or srf-3/ic (Fig. 4). Infectious center assays
showed that P226S had significantly increased infectivity
on depleted cells (Fig. 5 
 
A
 
), and fusion assays showed an
increase of greater than four logs in P226S fusion with the
depleted cell plasma membrane (Fig. 5 
 
B
 
). The exit of
P226S was compared to that of srf-3 and wt SFV by pulse-
chase analysis of control and cholesterol-depleted cells.
Cells were infected with mutant or wt viruses, pulse la-
beled for 15 min, and chased for 3 h. Radiolabeled virus
spike proteins were immunoprecipitated from the cell ly-
sates and chase media, and exit quantitated by gel electro-
phoresis and phosphorimaging. Increased multiplicity of
wt virus infection was used to circumvent the fusion block
and express the wt virus in depleted cells (Marquardt et al.,
1993). Efficient and comparable exit of all three viruses
was observed from control cells (Fig. 6 
 
A
 
), with 53, 51, or
46% release of total radiolabeled spike proteins from wt,
srf-3, or P226S-infected cells, respectively. As expected,
exit from cholesterol-deficient cells was inhibited for wt vi-
rus (2.4%), and was significantly more efficient for srf-3
(17%) (Fig. 6 
 
B
 
), in agreement with the increased release
of virus from depleted cells described for srf-3 above. The
P226S mutant also showed increased efficiency of exit in
the absence of cholesterol (12%). These data demonstrate
that a single amino acid change, P226S, is responsible for
the relative cholesterol-independence of both srf-3 fusion
and exit.
Figure 4. The growth properties of srf-3 are conferred by the E1
P226S mutation. The growth of wt, srf-3, and viruses derived from
the pSP6-SFV-4 infectious clone (wt/ic), pSP6-SFV-4 containing the
NdeI fragment of srf-3 (srf-3/ic), and pSP6-SFV-4 containing the
P226S mutation was determined on cholesterol-depleted C6/36
cells as in Fig. 1. Representative example of two experiments.
Figure 5. The srf-3 choles-
terol-independent infectivity
and fusion properties are
conferred by the E1 P226S
mutation. (A) Infection. Pri-
mary infection by viruses de-
rived from the pSP6-SFV-4
infectious clone (wt/ic) and
pSP6-SFV-4 containing the
P226S mutation was deter-
mined on control (1) or cho-
lesterol-depleted (2) C6/36
cells as in Fig. 2, and normal-
ized to 105 infectious centers/
ml on control cells. Average
of two experiments. (B) Fu-
sion. Fusion of viruses de-
rived from the pSP6-SFV-4
infectious clone (wt/ic) and
pSP6-SFV-4 containing the
P226S mutation was deter-
mined on control (1) or cho-
lesterol-depleted (2) C6/36
cells as in Fig. 2, and normal-
ized to 107 infectious centers/
ml on control cells. Average
of two experiments.Vashishtha et al. A Novel Mutation Affects Virus Cholesterol Dependence 97
The amino acid sequence surrounding P226 was com-
pared for the known alphavirus E1 sequences (Fig. 7).
This is a conserved area of the E1 polypeptide, with a
number of residues that are invariant among 11 different
alphaviruses, including the flanking residues leucine 221,
histidine 230, and prolines 224 and 232. However, P226 it-
self is not conserved. At the corresponding position it is a
proline residue in the closely related Ross River virus, but
alanine in a number of other alphaviruses, and valine in
western equine encephalitis virus. Notably, none of the re-
ported alphavirus sequences contain serine at this posi-
tion. Sequence comparisons showed no significant identity
between this region and other, non-alphavirus sequences
in the database. Our studies thus have identified a previ-
ously uncharacterized region of SFV E1, separate from the
fusion peptide, that is involved in the requirement for cho-
lesterol, during virus fusion and exit.
Discussion
In summary, our data indicate that SFV fusion and exit are
highly cholesterol dependent, and that this sterol require-
ment is significantly reduced by the P226S mutation. Inter-
estingly, preliminary data from our lab indicate that two
independent mutants selected for cholesterol-independent
growth also have the P226S mutation, supporting the im-
portance of this region of the spike protein in the virus
cholesterol requirement (Chatterjee, P., and M. Kielian,
unpublished results). It is striking that although it is not
conserved, the position analogous to SFV E1 P226 is not
found as a serine residue in any of the alphavirus se-
quences in the database, including recent virus isolates
from nature (Fig. 7). Other nonconserved proline residues
in this and other E1 regions (eg., P237; Fig. 7) are present
as a serine in some alphavirus sequences. Preliminary re-
sults with Sindbis virus, having alanine at position 226,
indicate that both its infection and fusion are highly cho-
lesterol dependent, similar to wt SFV (Lu, Y., and M. Kie-
lian, unpublished results). Although other mechanisms are
possible, it therefore appears most likely that the gain of
serine 226, rather than the loss of the proline at this posi-
tion, is responsible for the relative cholesterol indepen-
dence of srf-3. Although all of the alphaviruses have not
been tested, it seems probable that the other members of
this genus will require cholesterol for fusion, similar to
SFV and Sindbis. By analogy with the SFV studies (Nieva
et al., 1994), we also presume that sphingolipids will be
necessary for the fusion of other alphaviruses. Taken to-
gether, these observations fit a model in which highly cho-
lesterol-dependent infection is an important characteristic
of all alphaviruses, and is somehow selected for in vivo.
Further in vivo and in vitro studies will be required to de-
termine the lipid dependence of other alphaviruses, and
the existence of a possible selection pressure for highly
cholesterol-dependent alphavirus fusion.
In general, it is not known if members of other virus
families have specific lipid requirements for membrane fu-
sion or virus egress. In vitro and/or in vivo studies of influ-
enza virus, a myxovirus, and vesicular stomatitis virus, a
rhabdovirus, suggest that both viruses have fusion mecha-
nisms independent of either cholesterol or sphingolipid
(White et al., 1982; Eidelman et al., 1984; Phalen and Kie-
lian, 1991; Cleverley et al., 1997). Cholesterol does seem to
enhance fusion of Sendai virus, a paramyxovirus whose fu-
sion protein bears structural and sequence similarities to
that of influenza (Hsu et al., 1983; Kundrot et al., 1983).
Many medically important viruses such as HIV-1 have not
yet been tested for lipid requirements in fusion or infec-
tion. It is interesting that during budding, HIV-1 appears
to select for significantly increased concentrations of both
cholesterol and sphingomyelin in the virus membrane
compared to the cell plasma membrane (Aloia et al.,
1993). It is not known if this selectivity represents an ac-
tual lipid requirement for HIV-1 budding.
There are several precedents for protein–cholesterol
interactions important in membrane biology. Caveolin, an
integral component of specialized membrane domains
known as caveolae (Rothberg et al., 1992), binds choles-
terol (Murata et al., 1995) and may be involved in trans-
Figure 6. Cholesterol-inde-
pendent SFV exit is conferred
by the E1 P226S mutation.
Control or cholesterol-
depleted  C6/36 cells were in-
fected with the indicated vi-
ruses at muliplicities of 50
pfu/cell, except for wt/ic in
depleted cells, for which the
multiplicity was 1,000 pfu/
cell. 18 h postinfection, the
release of progeny virus was
detemined by pulse-labeling for 15 min with [35S]methionine and
cysteine, chasing for 3 h in the presence of excess cold methionine
and cysteine, collecting the chase medium, and lysing the cells.
The amount of radiolabeled virus spike proteins in the cells (C)
and media (M) was determined by immunoprecipitation and
SDS-PAGE. Representative example of two experiments.
Figure 7. Sequence comparison of the P226 E1 region in alphavi-
ruses. Amino acid numbering is given for SFV E1, starting with
residue 215, and P226 is shown in bold. Abbreviations and acces-
sion numbers are as follows, other sequence references are listed
in (Strauss and Strauss, 1994; Kielian, 1995): SFV (Semliki Forest
virus); RRV (Ross River virus); ONN (O’Nyong-nyong virus);
CHIK (Chikungunya virus) (NCBI 576465); EEE (Eastern
equine encephalitis virus); VEE (Venezuelan equine encephalitis
virus); AURA (Aura virus); WEE (Western equine encephalitis
virus); WHATE (Whataroa virus) (unpublished data from Drs.
Y. Shirako and J. Strauss); OCK (Ockelbo virus); SV (Sindbis virus).The Journal of Cell Biology, Volume 140, 1998 98
port of sterol from the endoplasmic reticulum to the
plasma membrane (Smart et al., 1996). The caveolin resi-
dues involved in sterol binding are not yet identified. Sev-
eral proteins involved in cellular cholesterol metabolism
have membrane-spanning domains that may act as choles-
terol sensors, although the specific cholesterol–interaction
site has yet to be identified (Brown and Goldstein, 1997).
The thiol-activated cytolysins are bacterial toxins that act
by binding cholesterol in the target cell membrane, insert-
ing into the membrane, and oligomerizing to form a pore
(Alouf and Geoffroy, 1991). Similar to the SFV E1 pro-
tein, these toxins appear to require the sterol 3b-hydroxyl
group for their activity, and at least one, lysteriolysin O,
has an acid pH optimum for cholesterol binding and pore
formation (Portnoy et al., 1992). The crystal structure of a
member of this family, perfringolysin O, was recently de-
termined (Rossjohn et al., 1997). The putative cholesterol-
binding site is composed of noncontiguous amino acid res-
idues, and involves interactions with aliphatic side chains
and hydrogen bonding between the sterol 3b-hydroxyl and
glutamate and arginine residues. Cholesterol oxidase is an
enzyme that specifically oxidizes the sterol 3b-hydroxyl
group. The crystal structure of the enzyme with a bound
sterol substrate shows that the binding site is a solvent-
sealed internal cavity in which the sterol rings have exten-
sive contacts and the sterol hydroxyl is hydrogen-bonded
to a flovin adenine dinucleotide cofactor and a bound wa-
ter molecule (Li et al., 1993). Thus, work from other sys-
tems suggests that sterol binding is likely to involve non-
contiguous residues that interact with the sterol ring
structure and hydrogen bond with the sterol hydroxyl. The
SFV E1 protein does not show significant regions of se-
quence identity with these other cholesterol-binding pro-
teins. It remains to be seen if similar binding sites or motifs
for cholesterol interaction exist among these molecules.
What might be the mechanism by which the gain of
serine 226 confers srf-3 cholesterol independence? One in-
triguing possibility is that the serine hydroxyl group may
act as a substitute for the critical 3b-hydroxyl group of
cholesterol. The mutation could act by “filling” a choles-
terol-binding site either within the P226 region or in an in-
teracting domain of E1. If this is the case, the mutation
could cause a normally cholesterol-requiring step in fusion
to be less cholesterol dependent. During low pH-triggered
fusion, E1 undergoes at least three separate conforma-
tional changes: exposure of new epitopes, formation of a
homotrimer, and hydrophobic association with the target
membrane bilayer (Kielian, 1995; Kielian et al., 1996). Pre-
liminary data indicate that srf-3 E1 is less cholesterol de-
pendent than wt for both epitope exposure and homotri-
mer formation (Chatterjee, P., M. Vashishtha, and M.
Kielian, unpublished data). Further studies will focus on
the role of the serine hydroxyl and on the potential inter-
actions of this region with other spike protein domains.
The most surprising finding of this study is that a single
point mutation in E1 substitutes for the specific choles-
terol requirement in both SFV fusion and exit. The exact
step in the SFV exit pathway that requires cholesterol has
not been determined, but our data suggest that the most
likely site is at a point after arrival of the spike protein at
the cell surface (Marquardt et al., 1993). It is unlikely that
E1’s fusion activity is directly required for virus exit. Dur-
ing virus budding, the forming virus particle must pinch off
in a membrane fission reaction, but unlike virus mem-
brane fusion, this occurs at neutral pH. In addition, virus
mutants that are completely blocked in membrane fusion
(Duffus et al., 1995) or have a dramatically acid-shifted pH
threshold for fusion (Salminen et al., 1992; Duffus et al.,
1995) can still assemble into virus particles. Computer re-
constructions of alphaviruses indicate that almost all of the
surface of the particle is covered by a spike protein shell,
with very little of the lipid bilayer exposed (Cheng et al.,
1995; Fuller et al., 1995). However, in spite of the fact that
the majority of the cholesterol in the virus membrane bi-
layer appears inaccessible, cholesterol-depleted virus is
highly destabilized. The requirement for cholesterol in both
efficient wt virus exit and virus particle stability suggests
that cholesterol is important in the normal spike protein
interactions involved in formation of the alphavirus parti-
cle. The phenotype of the srf-3 mutant suggests that these
interactions are mediated by spike protein domains that
are also required for membrane fusion.
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